Updates
Drummond Group Announces Completion of LedgerDomain OCI Digital Wallet Compliance Criteria Audit
LedgerDomain has successfully completed OCI Digital Wallet Conformance Criteria Audit to validate Pharmaceutical Authorized Trading Partners (ATP).
Drummond Group Announces Completion of Legisym OCI Credential Issuer Conformance Criteria Audit
Legisym First to Complete Compliance Audit to OCI Credential Issuer Conformance Criteria to Validate Pharmaceutical Authorized Trading Partners (ATP)
DSCSA 2024 or 2023 Déjà Vu?
A look at the challenges that need to be addressed during the FDA Stabilization Period.
Drummond Group Announces Completion of Spherity OCI Digital Wallet Compliance Criteria Audit
Spherity First to Complete Compliance Audit To OCI Digital Wallet Conformance Criteria to Validate Pharmaceutical Authorized Trading Partners (ATP)
LedgerDomain and Spherity Surpass OCI Performance Standards in Latest API Tests
LedgerDomain and Spherity, leading providers in digital credentialing services, today announced results from their latest performance testing, exceeding the current OCI requirements for the U.S. pharmaceutical supply chain under DSCSA.
Are you concerned over DSCSA implementation and supply chain disruption?
Four major DSCSA violation observations were recently made by the FDA. The warning issued by FDA confirms not prioritizing any of the DSCSA requirements will not slip in their inspections.
The Center for Supply Chain Studies Launches DSCSA Tracing Pilot to Drive Pharmaceutical Supply Chain Interoperability
The Center for Supply Chain Studies (C4SCS) is proud to announce the commencement of its DSCSA Tracing Pilot and Exploration Sandboxes. As part of this initiative, pharmaceutical manufacturers, wholesalers, hospitals, retail pharmacies, and solution providers have new tools to achieve enhanced drug distribution security as mandated by the U.S. Drug Supply Chain Security Act (DSCSA).
Guest Blog: Spherity — EU Digital Product Passports and enabling compliance in the US pharmaceutical supply chain
In the DIF guest blog, the Spherity team explains how they leverage decentralized identity capabilities in their work on Digital Product Passports in the EU and promote compliance with the new pharmaceutical industry regulations, DSCSA in the US.
XATP, Spherity, Trust.med, and Legisym Announce Interoperable Effort to Secure DSCSA Verification, Tracing, and Recalls
XATP, Spherity, Trust.med, and Legisym announced interoperability between their digital wallet, credentialing, and routing services in support of secured enhanced verification and tracing activities required by the U.S. Drug Supply Chain Security Act (DSCSA).
XATP and Spherity Announce Interoperability for DSCSA Credentialing
XATP and Spherity announced interoperability between their digital wallet services in support of regulatory compliance with the U.S. Drug Supply Chain Security Act (DSCSA) by fall 2023. This key milestone enables trading partners using either platform to securely exchange and verify each other’s credentials as Authorized Trading Partners (ATPs).